Intensity Therapeutics Inc

NASDAQ:INTS   4:00:00 PM EDT
0.31
-0.01 (-4.06%)
: $0.30 -0.01 (-1.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Intensity Therapeutics Inc Stock, NASDAQ:INTS

1 Enterprise Drive, Suite 430, Shelton, Connecticut 06484-4779
United States of America
Phone: +1.203.221.7381
Number of Employees: 16
http://www.intensitytherapeutics.com

Description

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.